Published in Science on August 24, 1973
Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend (2008) 1.60
Drugs and firearm deaths in New York City, 1990-1998. J Urban Health (2002) 1.12
A decline in the prevalence of injecting drug users in Estonia, 2005-2009. Int J Drug Policy (2013) 0.80
Addiction in medicine. Trans Am Clin Climatol Assoc (2008) 0.77
The rise of the modern addict. Am J Public Health (1995) 0.76
An epidemiologic assessment of heroin use. Am J Public Health (1974) 0.75
Use of drugs among persons admitted to a country jail. Public Health Rep (1976) 0.75
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03
Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry (1999) 2.97
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med (1985) 2.54
The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst (1998) 2.53
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry (1999) 2.44
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet (2005) 2.13
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer (1980) 2.04
Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA (1978) 1.74
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci U S A (1983) 1.72
Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer (2004) 1.64
Amyl nitrite may alter T lymphocytes in homosexual men. Lancet (1982) 1.54
Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54
Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. J Natl Cancer Inst (1978) 1.53
High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med (1985) 1.51
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
The high way: driving under influences other than alcohol. JAMA (1992) 1.38
Profile of a heroin-addiction epidemic. N Engl J Med (1971) 1.38
Malignant melanoma in renal-transplant recipients. Lancet (1981) 1.33
Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31
Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med (1982) 1.29
Familial and sporadic Hodgkin's disease associated with occupational wood exposure. Lancet (1978) 1.26
Radiogenic male breast cancer with in vitro sensitivity to ionizing radiation and bleomycin. Cancer Invest (1983) 1.24
Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med (1986) 1.23
Twelve-step and mutual-help programs for addictive disorders. Psychiatr Clin North Am (1999) 1.22
Evidence against Ha-ras-1 involvement in sporadic and familial melanoma. Nature (1987) 1.21
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Arch Gen Psychiatry (1988) 1.12
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med (1983) 1.12
Mycosis fungoides: epidemiologic observations. Cancer Treat Rep (1979) 1.11
Cancer mortality among printing plant workers. Environ Res (1979) 1.10
Impact of the Sahelian drought in Mauritania, West Africa. Lancet (1974) 1.10
Benzodiazepines in a health-catalog product. JAMA (1990) 1.07
Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer (2008) 1.05
Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study. Public Health Genomics (2010) 1.05
NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas. Ann Intern Med (1981) 1.04
An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med (1980) 1.03
Cancer trends in a population at risk of acquired immunodeficiency syndrome. J Natl Cancer Inst (1985) 1.02
Control of alcohol and drug abuse in industry--a literature review. Public Health Rep (1980) 1.00
Dysplastic naevi and cutaneous melanoma risk. Lancet (1983) 0.99
Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. Natl Cancer Inst Monogr (1985) 0.98
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr (1983) 0.98
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N Engl J Med (1987) 0.97
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma. Cancer Res (1983) 0.96
Marijuana and benzodiazepines in patients receiving methadone treatment. JAMA (1989) 0.94
The epidemiology of ovarian cancer. Semin Oncol (1984) 0.93
Opiate "overdose" deaths in the District of Columbia. I. Heroin-related fatalities. Med Ann Dist Columbia (1974) 0.93
Dysplastic naevi in a population-based survey. Cancer (1989) 0.92
Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility. Cancer Res (1986) 0.92
Common genetic variants in the 9p21 region and their associations with multiple tumours. Br J Cancer (2013) 0.92
Disseminated cryptococcosis presenting as palpable purpura. Arch Intern Med (1978) 0.91
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanoma. J Am Acad Dermatol (1987) 0.91
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2009) 0.90
The origins of the Minnesota model of addiction treatment--a first person account. J Addict Dis (1999) 0.90
Abnormal sensitivity to UV-radiation in cultured skin fibroblasts from patients with hereditary cutaneous malignant melanoma and dysplastic nevus syndrome. Int J Cancer (1982) 0.90
Narcotics and crime: a study of narcotic involvement in an offender population. Int J Addict (1972) 0.89
Alprazolam and benzodiazepine dependence. J Clin Psychiatry (1993) 0.88
A preliminary report on crime and addiction within a community-wide population of narcotic addicts. Drug Alcohol Depend (1977) 0.87
Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary. Am J Obstet Gynecol (1984) 0.87
Precursor lesions in familial melanoma. Semin Oncol (1978) 0.86
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. Arch Gen Psychiatry (1988) 0.86
Abnormal responses to the carcinogen 4-nitroquinoline 1-oxide of cultured fibroblasts from patients with dysplastic nevus syndrome and hereditary cutaneous malignant melanoma. Carcinogenesis (1983) 0.85
Hypersensitivity to G2 chromatid radiation damage in familial dysplastic naevus syndrome. Lancet (1987) 0.85
A stratified genetic risk assessment for testicular cancer. Int J Androl (2011) 0.84
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry (1988) 0.84
Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide. Proc Natl Acad Sci U S A (1984) 0.84
Scaphoid fractures in children. J Hand Surg Am (1984) 0.83
Development of a heroin-addiction treatment program. Effect on urban crime. JAMA (1971) 0.83
Heroin addiction trends. Am J Psychiatry (1974) 0.83
Clinical and laboratory observations in a lymphoma-prone family. Cancer (1987) 0.82
Hairy cell leukemia in three siblings: an apparent HLA-linked disease. Cancer (1982) 0.82
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). Br J Cancer (2009) 0.82
Nasopharyngeal cancer among young people in the United States: racial variations by cell type. J Natl Cancer Inst (1977) 0.82
Evolving patterns of drug abuse. Ann Intern Med (1975) 0.82
Sister chromatid exchanges and chromosomes in chronic myelogenous leukemia and cancer families. Int J Cancer (1979) 0.82
Bipartite hamulus with ulnar tunnel syndrome--case report and literature review. J Hand Surg Am (1981) 0.82
Opiate overdose deaths in the District of Columbia. II. Methadone-related fatalities. J Forensic Sci (1974) 0.81
Another cause of irreducible dislocation of the proximal interphalangeal joint of a finger. J Bone Joint Surg Am (1966) 0.81
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. Arch Dermatol (1981) 0.81
Polydrug abuse and the maturing national drug abuse data base. Ann N Y Acad Sci (1976) 0.81
Family history of breast cancer as a determinant of the risk of developing endometrial cancer: a nationwide cohort study. J Med Genet (2002) 0.81
Quantification of the cellular components of breast duct lavage samples. Diagn Cytopathol (2006) 0.81
Gail model and breast cancer. Lancet (2000) 0.81
Colorectal cancer in rural Nebraska. Cancer Res (1984) 0.81
Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population. Genet Test (2001) 0.81
Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma. Dermatol Clin (1985) 0.80
Managing the dysplastic naevus syndrome. Lancet (1984) 0.80
Controlling the abuse of illicit methadone in Washington, DC. Arch Gen Psychiatry (1975) 0.80
Subsequent cancer in patients with Ewing's sarcoma. Cancer Treat Rep (1980) 0.79
Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation. Cancer Res (1988) 0.79
Carmustine as a cause of acute nonlymphocytic leukemia. N Engl J Med (1985) 0.79
Endogenous DNA damage and testicular germ cell tumors. Int J Androl (2008) 0.79
Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet (1987) 0.79
The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol (1983) 0.79